Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats

Hypertension Research

Volumn 33, Issue 2, 2010, Pages 135-142

  Satoh, Minoru ^a   Haruna, Yoshisuke ^a   Fujimoto, Sohachi ^a   Sasaki, Tamaki ^a   Kashihara, Naoki ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin receptor blocker; ENOS uncoupling; Nitric oxide; Superoxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; NITRIC OXIDE; PURINERGIC P2X1 RECEPTOR; SUPEROXIDE; TELMISARTAN; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY ENDOTHELIUM; ARTICLE; AUTOREGULATION; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; GLOMERULUS; KIDNEY ARTERY; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY PERFUSION; MALE; NONHUMAN; PERFUSION PRESSURE; RENAL AUTOREGULATION; RENOVASCULAR HYPERTENSION; SPECTROFLUOROMETRY; VASODILATATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; BIOPTERIN; BLOTTING, WESTERN; ENDOTHELIUM, VASCULAR; HOMEOSTASIS; KIDNEY; KIDNEY GLOMERULUS; MALE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, INBRED DAHL; REACTIVE OXYGEN SPECIES; RECEPTORS, PURINERGIC P2;

EID: 76349118060     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.190     Document Type: Article

References (48)

1. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18.
2. Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 2003; 41: 1341-1345.
3. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric non-diabetic nephropathy. Lancet 1997; 349: 1857-1863.
4. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA 1992; 268: 3085-3091.
5. Feld LG, Van Liew JB, Galaske RG, Boylan JW. Selectivity of renal injury and proteinuria in the spontaneously hypertensive rat. Kidney Int 1977; 12: 332-343.
6. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-844.
7. Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitric-oxide synthases. J Biol Chem 2001; 276: 14533-14536.
8. Oelze M, Mollnau H, Hoffmann N, Warnholtz A, Bodenschatz M, Smolenski A, Walter U, Skatchkov M, Meinertz T, Munzel T. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res 2000; 87: 999-1005.
9. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001; 88: E14-E22.
10. Xia Y, Tsai AL, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 1998; 273: 25804-25808.
11. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard Jr KA. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 1998; 95: 9220-9225. (Pubitemid 28506212)
12. Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydro-biopterin in vascular disease. Arterioscler Thromb Vasc Biol 2004; 24: 413-420.
13. Persson PB. Renal blood flow autoregulation in blood pressure control. Curr Opin Nephrol Hypertens 2002; 11: 67-72.
14. Inscho EW, Carmines PK, Cook AK, Navar LG. Afferent arteriolar responsiveness to altered perfusion pressure in renal hypertension. Hypertension 1990; 15: 748-752.
15. Inscho EW, Imig JD, Deichmann PC, Cook AK. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats. J Am Soc Nephrol 1999; 10(Suppl 11): S178-S183.
16. Haruna Y, Morita Y, Yada T, Satoh M, Fox DA, Kashihara N. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis. Arthritis Rheum 2007; 56: 1827-1835.
17. Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H, Komai N, Sasaki T, Tsujioka K, Makino H, Kashihara N. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 2005; 288: F1144-F1152.
18. Fujimoto S, Satoh M, Horike H, Hatta H, Haruna Y, Kobayashi S, Namikoshi T, Arakawa S, Tomita N, Kashihara N. Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production. Hypertens Res 2008; 31: 305-313.
19. Satoh M, Fujimoto S, Arakawa S, Yada T, Namikoshi T, Haruna Y, Horike H, Sasaki T, Kashihara N. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy. Nephrol Dial Transplant 2008; 23: 3806-3813.
20. Namikoshi T, Tomita N, Satoh M, Haruna Y, Kobayashi S, Komai N, Sasaki T, Kashihara N. Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein. Am J Hypertens 2007; 20: 1085-1091.
21. van Dokkum RP, Sun CW, Provoost AP, Jacob HJ, Roman RJ. Altered renal hemody-namics and impaired myogenic responses in the fawn-hooded rat. Am J Physiol 1999; 276: R855-R863.
22. Semple SJ, De Wardener HE. Effect of increased renal venous pressure on circulatory autoregulation of isolated dog kidneys. Circ Res 1959; 7: 643-648.
23. Taylor NE, Maier KG, Roman RJ, Cowley Jr AW. NO synthase uncoupling in the kidney of Dahl S rats: role of dihydrobiopterin. Hypertension 2006; 48: 1066-1071.
24. Fujii S, Zhang L, Igarashi J, Kosaka H. L-arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats. Hypertension 2003; 42: 1014-1020.
25. Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clin Sci (Lond) 2005; 109: 217-226.
26. Squadrito GL, Pryor WA. The formation of peroxynitrite in vivo from nitric oxide and superoxide. Chem Biol Interact 1995; 96: 203-206.
27. Xu J, Wu Y, Song P, Zhang M, Wang S, Zou MH. Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 2007; 116: 944-953.
28. Xu J, Xie Z, Reece R, Pimental D, Zou MH. Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Arterioscler Thromb Vasc Biol 2006; 26: 2688-2695.
29. Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U, Schulz E, Mollnau H, von Sandersleben A, Kleschyov AL, Mulsch A, Li H, Forstermann U, Munzel T. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 2006; 48: 677-684.
30. Barton M, Vos I, Shaw S, Boer P, D'Uscio LV, Grone HJ, Rabelink TJ, Lattmann T, Moreau P, Luscher TF. Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophyandGlomerulosclerosis J Am Soc Nephrol 2000; 11:835-845
31. Karlsen FM, Andersen CB, Leyssac PP, Holstein-Rathlou NH. Dynamic autoregulation and renal injury in Dahl rats. Hypertension 1997; 30: 975-983.
32. Bidani AK, Hacioglu R, Abu-Amarah I, Williamson GA, Loutzenhiser R, Griffin KA. 'Step' vs'dynamic' autoregulation: implications for susceptibility to hypertensive injury. Am J Physiol Renal Physiol 2003; 285: F113-F120.
33. Cupples WA, Braam B. Assessment of renal autoregulation. Am J Physiol Renal Physiol 2007; 292: F1105-F1123.
34. Ungvari Z, Koller A. Selected contribution: NO released to flow reduces myogenic tone of skeletal muscle arterioles by decreasing smooth muscle Ca(2+) sensitivity. J Appl Physiol 2001; 91: 522-527 discussion 504-525.
35. Huang A, Sun D, Kaley G, Koller A. Superoxide released to high intra-arteriolar pressure reduces nitric oxide-mediated shear stress-and agonist-induced dilations. Circ Res 1998; 83: 960-965.
36. Nurkiewicz TR, Boegehold MA. High salt intake reduces endothelium-dependent dilation of mouse arterioles via superoxide anion generated from nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1550-R1556.
37. Rahgozar M, Guan Z, Matthias A, Gobe GC, Endre ZH. Angiotensin II facilitates autoregulation in the perfused mouse kidney: An optimized in vitro model for assessment of renal vascular and tubular function. Nephrology (Carlton) 2004; 9: 288-296.
38. Guan Z, Willgoss DA, Matthias A, Manley SW, Crozier S, Gobe G, Endre ZH. Facilitation of renal autoregulation by angiotensin II is mediated through modulation of nitric oxide. Acta Physiol Scand 2003; 179: 189-201.
39. Mitchell KD, Navar LG. Enhanced tubuloglomerular feedback during peritubular infusions of angiotensins I and II. Am J Physiol 1988; 255: F383-F390.
40. Ichihara A, Hayashi M, Koura Y, Tada Y, Sugaya T, Hirota N, Saruta T. Blunted tubuloglomerular feedback by absence of angiotensin type 1A receptor involves neuronal NOS. Hypertension 2002; 40: 934-939.
41. Leyssac PP, Holstein-Rathlou NH. Tubulo-glomerular feedback response: enhancement in adult spontaneously hypertensive rats and effects of anaesthetics. Pflugers Arch 1989; 413: 267-272.
42. Rapp JP, Tan SY, Margolius HS. Plasma mineralocorticoids, plasma renin, and urinary kallikrein in salt-sensitive and salt-resistant rats. Endocr Res Commun 1978; 5: 35-41.
43. Muller-Suur R, Gutsche HU, Samwer KF, Oelkers W, Hierholzer K. Tubuloglomerular feedback in rat kidneys of different renin contents. Pflugers Arch 1975; 359: 33-56.
44. Schnermann J, Levine DZ. Paracrine factors in tubuloglomerular feedback: adenosine, ATP, and nitric oxide. Annu Rev Physiol 2003; 65: 501-529.
45. Inscho EW. P2 receptors in regulation of renal microvascular function. Am J Physiol Renal Physiol 2001; 280: F927-F944.
46. Schwiebert EM. ATP release mechanisms, ATP receptors and purinergic signalling along the nephron. Clin Exp Pharmacol Physiol 2001; 28: 340-350.
47. Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ. Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest 2003; 112: 1895-1905.
48. Mulvany MJ. Small artery remodelling in hypertension: causes, consequences and therapeutic implications. Med Biol Eng Comput 2008; 46: 461-467.